SMT201600216B
(en )
2016-08-31
OCTAIDROPIRROL [3,4.C] PIRROLS DISTRIBUTED AS MODULATORS OF OREXINA RECEPTOR
BRPI0808775A2
(en )
2017-05-30
compounds and compositions as modulators of gpr119 activity
BRPI0910503A2
(en )
2015-09-29
compounds, pharmaceutical compositions and their uses.
TN2010000122A1
(en )
2011-09-26
Compounds and compositions as modulators of gpr119 activity
IN2012DN02471A
(en )
2015-08-21
BRPI0807987A2
(en )
2014-06-24
COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS.
SMT201700105B
(en )
2017-03-08
NEW COMPOSITIONS TO PREVENT AND / OR TREAT DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM
EA201001329A1
(en )
2011-04-29
COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
CO6280490A2
(en )
2011-05-20
4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE
EA201001332A1
(en )
2011-04-29
COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
BRPI0911577A8
(en )
2018-03-06
spiroindole derivatives for the treatment of parasitic diseases.
EA201001330A1
(en )
2011-04-29
COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
MA31413B1
(en )
2010-06-01
NOVEL DIOSMETIN DERIVATIVES, THEIR PHARMACEUTICAL PREPARATION PROCESS CONTAINING THEM.
AP2011005978A0
(en )
2011-12-31
2, 4 diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation.
WO2012031164A3
(en )
2012-08-16
Drug delivery by carbon nanotube arrays
ITTO20110634A1
(en )
2012-01-22
METHOD FOR TREATING ORGANIC DISEASES OF THE NERVOUS SYSTEM, THE PSYCHOORGANIC SYNDROME AND THE SYNTHALOPATHY
BRPI1015472A2
(en )
2015-11-24
methods for prevention and / or treatment of degenerative diseases of the central nervous system
GB201302343D0
(en )
2013-03-27
Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
ATE531715T1
(en )
2011-11-15
1,3-DIHYDRO-2H-PYRROLOÄ3.2-BÜPYRIDINE-2-ONDERIVA E, THEIR PRODUCTION AND THEIR THERAPEUTIC USES
WO2011014520A3
(en )
2011-06-23
Compounds and compositions as modulators of gpr119 activity
ZA201202492B
(en )
2013-02-27
Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
ITRE20080021U1
(en )
2010-04-10
HEALTH CHAIR FOR THOSE WHO ARE AFFECTED BY DEGENERATIVE DISEASES OF THE CENTRAL NERVOUS SYSTEM.
BR112014030059A2
(en )
2017-07-25
pharmaceutical formulations based on genotype or phenotype.
IT1396436B1
(en )
2012-11-23
COMPOSITION FOR THE PREVENTION AND TREATMENT OF ODONTOSTOMATOLOGICAL DISORDERS OF ANIMALS AND RELATED USES.
FR2953521B1
(en )
2011-11-18
NOVEL AZABICYCLO [3.1.0] HEX-2-YL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM